HeartBeam Partners with Mount Sinai to Develop AI-Powered ECG Algorithms
HeartBeam Inc. collaborates with Mount Sinai to advance AI-driven ECG technology, aiming to enhance remote cardiac monitoring and chronic condition management.
HeartBeam Inc. (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care, has entered into a strategic collaboration with Mount Sinai to develop and validate artificial intelligence (AI)-based electrocardiogram (ECG) algorithms. The partnership, highlighted in a recent article, underscores HeartBeam’s growing emphasis on AI-enabled analysis and reinforces the relevance of its technology as healthcare increasingly shifts toward data-driven, remote monitoring solutions.
The collaboration aims to create high-value AI models that can be deployed broadly across HeartBeam’s platform. These algorithms may include patient-relevant wellness insights, condition-focused assessments, and applications for chronic condition management. By integrating AI with its innovative 12-lead ECG technology, HeartBeam seeks to provide actionable cardiac intelligence outside traditional medical facilities, enabling physicians to identify health trends and acute conditions and direct patients to appropriate care.
HeartBeam is developing the first cable-free 12-lead ECG capable of capturing the heart’s electrical signals from three dimensions. This platform technology is designed for use in portable devices, allowing patients to receive cardiac monitoring wherever they are. The company holds 13 U.S. and 4 international issued patents related to its technology. According to the article, the partnership with Mount Sinai “highlights HeartBeam’s growing focus on AI-enabled analysis and reinforces the relevance of its technology as healthcare increasingly shifts toward data-driven, remote monitoring solutions.”
The news is significant as it positions HeartBeam at the forefront of AI-driven cardiac care, potentially improving patient outcomes through earlier detection and continuous monitoring. As healthcare systems worldwide adopt remote monitoring to reduce costs and improve access, HeartBeam’s collaboration with a leading academic medical center like Mount Sinai could accelerate the validation and adoption of its technology. The AI algorithms developed could also enhance the management of chronic conditions such as atrial fibrillation and heart failure, reducing hospitalizations and emergency visits.
For more details on the collaboration, the full article can be accessed here: https://ibn.fm/oTJHB. Additional information about HeartBeam is available on its website at www.HeartBeam.com.